MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,870,039
EPS
-$0.3
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
Research and development
182,386
Research and development - related parties
140,372
General and administrative
1,407,657
Total operating expenses
1,730,415
Loss from operations
-1,730,415
Other income
6,483
Interest expense
2,672
Change in fair value of derivative liabilities
0
Gain on settlement of liabilities
0
Total other (expense) income, net
3,811
Income (loss) before income taxes
-1,726,604
Income tax benefit
0
Net income (loss)
-1,726,604
Deemed dividend
0
Net income (loss) available to common stockholders
-1,726,604
Foreign currency translation adjustments
143,435
Total comprehensive loss
-1,870,039
Basic EPS
-0.3
Diluted EPS
-0.3
Basic Average Shares
5,708,126
Diluted Average Shares
5,708,126
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$1,870,039
Net income (loss)
available to common...
-$1,726,604
Foreign currency
translation adjustments
$143,435
Net income (loss)
-$1,726,604
Other income
$6,483
Income (loss) before
income taxes
-$1,726,604
Total other (expense)
income, net
$3,811
Interest expense
$2,672
Loss from operations
-$1,730,415
Total operating
expenses
$1,730,415
General and
administrative
$1,407,657
Research and development
$182,386
Research and development
- related parties
$140,372
Buy us a coffee
180 Life Sciences Corp. (ATNF)
180 Life Sciences Corp. (ATNF)